CV Sciences, Inc.
CVSI
$0.03
$0.00051.70%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.90% | 2.18% | -5.48% | -0.30% | -3.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.90% | 2.18% | -5.48% | -0.30% | -3.52% |
| Cost of Revenue | -9.35% | 7.19% | -7.08% | -6.85% | -9.17% |
| Gross Profit | -10.52% | -3.73% | -3.53% | 8.27% | 3.98% |
| SG&A Expenses | -12.23% | -12.18% | -10.27% | -22.09% | 13.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.22% | -3.42% | -8.84% | -14.87% | 386.37% |
| Operating Income | 101.77% | 36.83% | 40.27% | 89.30% | -110.76% |
| Income Before Tax | 83.60% | 15.72% | -2.01% | 54.55% | -110.90% |
| Income Tax Expenses | 16.67% | -55.56% | -- | -- | -- |
| Earnings from Continuing Operations | 82.64% | 16.46% | -2.01% | 54.66% | -111.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.64% | 16.46% | -2.01% | 54.66% | -111.01% |
| EBIT | 101.77% | 36.83% | 40.27% | 89.30% | -110.76% |
| EBITDA | 116.70% | 50.09% | 52.51% | 99.02% | -109.57% |
| EPS Basic | 84.62% | 30.36% | 13.79% | 59.52% | -110.40% |
| Normalized Basic EPS | 79.17% | 32.00% | 27.78% | 92.50% | -110.26% |
| EPS Diluted | 84.62% | 31.58% | 13.79% | 59.52% | -110.40% |
| Normalized Diluted EPS | 79.17% | 32.00% | 27.78% | 92.50% | -110.26% |
| Average Basic Shares Outstanding | 12.99% | 17.80% | 17.89% | 12.99% | 7.21% |
| Average Diluted Shares Outstanding | 12.99% | 17.80% | 17.89% | 12.99% | 7.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |